长风药业12月30日斥资83.02万港元回购2.4万股
Group 1 - The company, Changfeng Pharmaceutical (02652), announced a share buyback plan, intending to repurchase 24,000 shares at a cost of HKD 830,200 [1]
Group 1 - The company, Changfeng Pharmaceutical (02652), announced a share buyback plan, intending to repurchase 24,000 shares at a cost of HKD 830,200 [1]